Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Says Drug Improves COPD Symptoms
FOX Business
Tuesday, September 27, 2011 - 11:19am
tags:
COPD, Novartis, NVA237
FDA Panel, Bayer Birth Control Pills & Blood Clots
Pharmalot
Monday, September 26, 2011 - 10:30pm
tags:
advisory panels, blood clots, birth control pill, FDA, Bayer, Yasmin, Yaz
Alexion, Celgene Resilient Vs. Volatile Market
Investors.com
Monday, September 26, 2011 - 10:29pm
tags:
Celgene, Alexion, Soliris, Revlimid
Statins for Primary Prevention: the Debate Continues
Forbes
Monday, September 26, 2011 - 10:27pm
tags:
statins
How Eli Lilly Will Outwit Patent Expirations
Seeking Alpha
Monday, September 26, 2011 - 10:26pm
tags:
patents, Eli Lilly
Medicis Settles Case Alleging CEO Shacknai Cooked the Books
BNET Pharma
Monday, September 26, 2011 - 12:23pm
tags:
Medicis, Jonah Shacknai
2 Positive Signs for Ariad Pharmaceuticals
Motley Fool
Monday, September 26, 2011 - 12:21pm
tags:
Ariad Pharmaceuticals
Swiss paper totes up Novartis layoff count: 2,500
Fierce Pharma
Monday, September 26, 2011 - 12:10pm
tags:
Novartis, layoffs
Afinitor data could be 'game-changer' in breast cancer
Fierce Pharma
Monday, September 26, 2011 - 12:05pm
tags:
Afinitor, breast cancer, mTOR inhibitors, Pfizer, Aromasin
Bayer Drug Hailed As Prostate Cancer Game Changer
TheStreet.com
Monday, September 26, 2011 - 11:39am
tags:
Bayer, prostate cancer, Algeta, Amgen, Xgeva, Exelixis, Alpharadin
Pfizer Ratings Cut for Failure to Reduce Wyeth-Takeover Debt
Bloomberg
Monday, September 26, 2011 - 11:31am
tags:
debt, Pfizer, Wyeth, M&A
Roche expects $10 billion sales for HDL drug
Yahoo/Reuters
Monday, September 26, 2011 - 11:31am
tags:
Roche, HDL therapy, Merck, dalcetrapib, Anacetrapib
Teva breaking ground on $300M Phila. distribution center
Bizjournals.com
Monday, September 26, 2011 - 11:13am
tags:
Teva Pharmaceuticals, distribution
Lilly receives positive European opinion on Alimta
Yahoo/AP
Monday, September 26, 2011 - 11:12am
tags:
Europe, lung cancer, Alimta, Eli Lilly
Alexion Pharma on a High
Yahoo/Zacks.com
Monday, September 26, 2011 - 11:12am
tags:
Alexion, Soliris, aHUS, atypical hemolytic uremic syndrome
Jefferies analyst upgrades Alkermes to 'buy' after completion of acquisition, move to Ireland
Yahoo/AP
Monday, September 26, 2011 - 11:03am
tags:
Alkermes, M&A, drug delivery, Elan
Teva buys rest of Japan venture from Kowa at $150M
Marketwatch
Monday, September 26, 2011 - 11:00am
tags:
Kowa, Japan, Teva Pharmaceuticals, M&A
Cancer Cost Swells, Risks Becoming ‘Unsustainable,’ Lancet Says
Bloomberg
Monday, September 26, 2011 - 10:58am
tags:
cancer
9 Big Pharmas With The Least Side Effects
Seeking Alpha
Monday, September 26, 2011 - 10:57am
tags:
Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Human Genome Spikes On Sales: Good Time To Consider Buying
Seeking Alpha
Monday, September 26, 2011 - 10:56am
tags:
Human Genome Sciences, GSK, Benlysta, lupus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.